AI assistant
Sending…
CONMED Corp — Director's Dealing 2013
Apr 2, 2013
31971_dirs_2013-04-02_db025cc4-50b4-4a31-a58a-a5e58b6f6c4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-04-01
Reporting Person: Cohen Heather L (VP CORP HR&DEPUTY GEN COUNSEL)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-01 | Common Stock | M | 2564 | $31.40 | Acquired | 6251 | Direct |
| 2013-04-01 | Common Stock | S | 2564 | $34.00 | Disposed | 3687 | Direct |
| 2013-04-02 | Common Stock | M | 2436 | $31.40 | Acquired | 6123 | Direct |
| 2013-04-02 | Common Stock | S | 2436 | $34.00 | Disposed | 3687 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-04-01 | Options To Purchase Common Stock | $31.40 | M | 2564 | Disposed | 2015-05-17 | Common Stock (2564) | Direct |
| 2013-04-02 | Options To Purchase Common Stock | $31.40 | M | 2436 | Disposed | 2015-05-17 | Common Stock (2436) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 4, 2013.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 4, 2013.
F3: 5 year vesting schedule, 20% vesting each year starting 5/17/2006.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7